Cannabis
Recent articles
Cannabis may be rescheduled–what does it mean for neuroscience?
The drug could become much easier to access, increasing the number of researchers who can work with it and the manufacturers who can produce it.
Cannabis may be rescheduled–what does it mean for neuroscience?
The drug could become much easier to access, increasing the number of researchers who can work with it and the manufacturers who can produce it.
How organ-on-a-chip models can help drug development
This month’s Going on Trial newsletter explores how organ-on-a-chip models could smooth the transition from preclinical to clinical trials, among other drug development news.
How organ-on-a-chip models can help drug development
This month’s Going on Trial newsletter explores how organ-on-a-chip models could smooth the transition from preclinical to clinical trials, among other drug development news.
Prenatal exposures; Angelman trial suspension; autistic adult well-being
This month’s issue of the Null and Noteworthy newsletter breaks down some negative results involving prenatal exposures, an experimental treatment for Angelman syndrome, and the role that age at autism diagnosis plays in subsequent outcomes, and more.
Prenatal exposures; Angelman trial suspension; autistic adult well-being
This month’s issue of the Null and Noteworthy newsletter breaks down some negative results involving prenatal exposures, an experimental treatment for Angelman syndrome, and the role that age at autism diagnosis plays in subsequent outcomes, and more.
Cannabis compound rebalances signaling to quell seizures in mice
Cannabidiol (CBD) blocks the action of a molecule that drives an overexcitability feedback loop in a rodent model of epilepsy.
Cannabis compound rebalances signaling to quell seizures in mice
Cannabidiol (CBD) blocks the action of a molecule that drives an overexcitability feedback loop in a rodent model of epilepsy.
Explore more from The Transmitter
Scaling up n-of-1 trials; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 16 November.
Scaling up n-of-1 trials; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 16 November.
This paper changed my life: The salience network makes its mark
Vinod Menon’s 2008 PNAS paper found that activity in the salience network allows the brain to switch between different areas that control cognitive processing. The work drove Uddin to focus her research on large-scale brain networks and interactions among them.
This paper changed my life: The salience network makes its mark
Vinod Menon’s 2008 PNAS paper found that activity in the salience network allows the brain to switch between different areas that control cognitive processing. The work drove Uddin to focus her research on large-scale brain networks and interactions among them.
How does the developing brain make so many different types of neurons?
Oliver Hobert describes how analyzing patterns of gene expression and connectivity in closely and more distantly related species of nematodes sheds light on the structural and functional organization of the nervous system.
How does the developing brain make so many different types of neurons?
Oliver Hobert describes how analyzing patterns of gene expression and connectivity in closely and more distantly related species of nematodes sheds light on the structural and functional organization of the nervous system.